Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Risk | Very High | Very High |
Rating | - | - |
Min SIP Amount | ₹100 | ₹100 |
Expense Ratio | 2.05 | 2.26 |
NAV | ₹10.12 | ₹169.79 |
Fund Started | 04 Jul 2025 | 13 Oct 2005 |
Fund Size | ₹2017.44 Cr | ₹1420.55 Cr |
Exit Load | Exit Load for units in excess of 10% of the investment,1% will be charged for redemption within 12 months. | Exit load of 1% if redeemed within 15 days. |
Risk
Rating
Min SIP Amount
Expense Ratio
NAV
Fund Started
Fund Size
Exit Load
1 Year | - | 11.54% |
3 Year | - | 19.98% |
5 Year | - | 22.84% |
1 Year
3 Year
5 Year
Equity | 93.68% | 96.69% |
Cash | -0.19% | 3.31% |
Equity
Cash
Top 10 Holdings |
|
|
Top 10 Holdings
Name | Assets |
|---|---|
HDFC Bank Ltd. | 8.37% |
ICICI Bank Ltd. | 7.79% |
Bharti Airtel Ltd. | 7.40% |
Eternal Ltd. | 6.81% |
Bajaj Finance Ltd. | 4.88% |
Fortis Healthcare Ltd. | 4.08% |
Interglobe Aviation Ltd. | 4.07% |
PB Fintech Ltd. | 3.55% |
BSE Ltd. | 3.34% |
Apollo Hospitals Enterprise Ltd. | 3.34% |
Name | Assets |
|---|---|
Infosys Ltd. | 8.79% |
Reliance Industries Ltd. | 6.82% |
ICICI Bank Ltd. | 6.53% |
HDFC Bank Ltd. | 5.93% |
NTPC Ltd. | 4.63% |
Larsen & Toubro Ltd. | 4.59% |
Bharti Airtel Ltd. | 3.99% |
Sun Pharmaceutical Industries Ltd. | 3.69% |
Tata Consultancy Services Ltd. | 3.01% |
Dr. Reddy's Laboratories Ltd. | 2.87% |
Name | Shreyash Devalkar | Sri Sharma |
Start Date | 21 Nov 2025 | 30 Apr 2021 |
Name
Start Date
Description | The scheme seeks to provide long term capital appreciation from an actively managed portfolio of equity and equity related securities of companies belonging to the services industry. | The scheme seeks to generate capital appreciation and income distribution to unit holders by investing predominantly in equity/equity related securities of the companies belonging to Exports & Services industry. |
Launch Date | 04 Jul 2025 | 13 Oct 2005 |
Description
Launch Date